⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 6, 2026Current Opinion in NeurologyOpen Access

PET imaging of microglial pathology in multiple sclerosis

Olli Hartiala Joel Tuomaala Laura Airas

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to evaluate microglial pathology in multiple sclerosis using PET imaging.
Utilized PET imaging to assess brain inflammation in multiple sclerosis patients.
Compared findings with MRI results to determine detection capabilities of each method.
Evaluated glial responses to emerging neuroprotective therapies.
PET imaging identified inflammation that MRI could not detect.
Highlighted the role of microglial activity in the pathophysiology of MS.
Demonstrated potential for PET to guide therapeutic strategies in MS.

Implication

Research reveals PET imaging detects smouldering inflammation in multiple sclerosis, suggesting new therapeutic insights.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hartiala et al. (2026) studied this question.

synapsesocial.com/papers/69d896046c1944d70ce072f2 https://doi.org/10.1097/wco.0000000000001490

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Imaging neuroinflammation in multiple sclerosis using TSPO-PETreview · 2015 · 70 citations
2Illuminating Multiple Sclerosis: Next-Generation PET Tracers for Molecular Insights2025
3Activated microglia indicated by PET-[11C]PBR28 binding in multiple sclerosis correlates with MRI measures of inflammation and demyelination2025
4PET Molecular Probes for Neuroinflammation in Neurodegenerative Diseases: Progress and ProspectsReview · 2026 · 2 citations
5The association between the 1H-MR spectroscopy biomarker of astrogliosis and the PET biomarker of microglia in the thalamus in multiple sclerosis2025